David Graham: Profile

Dr David Graham is a top Consultant Gastroenterologist and Interventional Endoscopist at University College Hospital.

Training and Experience

Dr Graham strives to deliver high-quality care to his patients. This is achieved through taking a holistic approach in which his patients are listened to, their questions are answered and their needs understood and met. The main focus of his work is in the management of patients with acid reflux (heartburn), swallowing problems (in particular the management of strictures) and pre-malignant or malignant conditions of the stomach and oesophagus. Alongside this Dr Graham is passionate about his research focusing on providing high-quality diagnostic and therapeutic endoscopy, the early diagnosis of cancer and the long-term management of patients with pre-malignant conditions of their stomach or oesophagus. This work ensures that Dr Graham delivers up to date, leading care. Finally, Dr Graham is passionate about teaching and aids in hosting numerous live endoscopy workshops at UCH. This allows Dr Graham to embrace and deliver innovative endoscopic therapies to his patients.

Awards and Presentations

Dr Graham has won awards both nationally and internationally for his work in cancer prevention. He is regularly invited to speak at British and overseas conferences.

Membership of Professional Bodies

Dr Graham is a member of the British Society Of Gastroenterology

He is registered with the General Medical Council and is on the specialist register

Dr Graham is also a member of the Medical Defence Union

Research interests

2018 Zheng, S. C., Webster, A. P., Dong, D., Feber, A., Graham, D. G., Sullivan, R., Jevons, S., Lovat, L.B., Beck, S., Widschwendter, M., Teschendorff, A. E. (2018). A novel cell-type deconvolution algorithm reveals substantial contamination by immune cells in saliva, buccal and cervix. Epigenomics. doi:10.2217/epi-2018-0037

2017 Puccio, I., Khan, S., Butt, A., Graham, D., Sehgal, V., Patel, D., Hamoudi, R. A. (2018). Immunohistochemical assessment of Survivin and Bcl3 expression as potential biomarkers for NF-KB activation in the Barrett metaplasia-dysplasia-adenocarcinoma sequence. International Journal of Experimental Pathology. doi:10.1111/iep.12260 2016 Graham D, Lipman G, Sehgal V, Lovat L. Monitoring the pre-malignant potential of Barrett’s Oesophagus. Frontline Gastroenterology.

2016. Oct; 7(4): p316-322 2015 Graham DG, Banks MR. Advances in upper gastrointestinal endoscopy. F1000.  doi:  10.12688/f1000research.6961.1 2015 Haidry R, Graham D, Butt A, Lovat L. 2015. Advances in diagnostic and therapeutic endoscopy. Medicine.

2015. Volume 43, Issue 6, Pages 334–340 2015 Kohoutova D, Haidry R, Banks M, Bown S, Sehgal V, Butt MA, Graham D, Thorpe S, Novelli M, Rodriguez-Justo M, Lovat L. 2015. Esophageal neoplasia arising from subsquamous buried glands after an apparently successful photodynamic therapy or radiofrequency ablation for Barrett's associated neoplasia. Scand J Gastroenterol. 2015; 50(11): p1315-21

2015 Haidry RJ, Lipman G, Banks MR, Graham D.Novelli M, Lovat LB. 2015. Comparing endoscopic outcomes of patients with intramucosal carcinoma and high grade dysplasia arising in Barrett's Oesophagus: Experience from the United Kingdom registry. Endoscopy. 2015; 47(11): 980-987

2015 Rosenfeld A, Graham D, Hamoudi R, Butawan R, Eneh V, Khan S, Miah H, Niranjan M, Lovat L. MIAT: A Novel Attribute Selection Approach to Better Predict Upper Gastrointestinal Cancer. Data Science and Advanced Analytics. 2015. doi: 10.1109/DSAA.2015.7344866.

2015 Rosenfeld A. Graham D.G. Hamoudi R. Butawan R. Eneh V. Khan S. Miah H. Niranjan M. Lovat L.B. MIAT: A Novel Attribute Selection Approach to Better Predict Upper Gastrointestinal Cancer. IEEE 2015: 36678: 1-7